User menu

Cetuximab plus oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) for the epidermal growth factor receptor (EGFR)expressing metastatic colorectal cancer (mCRC) in the first-line setting: a phase II study

Bibliographic reference Cervantes, A. ; Humblet, Yves ; Casac, E. ; Van Cutsem, Emmanuel ; Sastre, J. ; et. al. Cetuximab plus oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) for the epidermal growth factor receptor (EGFR)expressing metastatic colorectal cancer (mCRC) in the first-line setting: a phase II study.In: EJC - Supplements, Vol. 3, no. 2, p. 181-182 (2005)
Permanent URL http://hdl.handle.net/2078.1/59850